Foghorn Therapeutics, Inc. (FHTX)
2.01
-0.03
(-1.47%)
USD |
NASDAQ |
Nov 10, 10:00
Foghorn Therapeutics Cash and Short Term Investments (Quarterly)
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 167.58M |
| March 31, 2026 | 184.88M |
| December 31, 2025 | 160.14M |
| September 30, 2025 | 181.53M |
| June 30, 2025 | 199.92M |
| March 31, 2025 | 220.59M |
| December 31, 2024 | 243.75M |
| September 30, 2024 | 267.40M |
| June 30, 2024 | 285.18M |
| March 31, 2024 | 206.66M |
| December 31, 2023 | 234.06M |
| September 30, 2023 | 259.89M |
| Date | Value |
|---|---|
| June 30, 2023 | 284.31M |
| March 31, 2023 | 315.97M |
| December 31, 2022 | 345.80M |
| September 30, 2022 | 373.52M |
| June 30, 2022 | 394.73M |
| March 31, 2022 | 424.74M |
| December 31, 2021 | 154.29M |
| September 30, 2021 | 120.84M |
| June 30, 2021 | 141.27M |
| March 31, 2021 | 160.92M |
| December 31, 2020 | 185.77M |
| September 30, 2020 | 75.16M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | 118.33M |
| Vaxcyte, Inc. | 1.292B |
| Connect Biopharma Holdings Ltd. | 31.49M |
| Caribou Biosciences, Inc. | 94.80M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |